ClinConnect ClinConnect Logo
Search / Trial NCT07077941

Comparing Integrative Midwife-led vs. Fragmented Inpatient Postpartum Care: Impact on Satisfaction and Transition to Motherhood

Launched by MEDICAL UNIVERSITY OF VIENNA · Jul 12, 2025

Trial Information

Current as of July 26, 2025

Not yet recruiting

Keywords

Postnatal Care Inpatient Maternity Competence Satisfaction Integrative Care Breastfeeding Maternal Behavior

ClinConnect Summary

This clinical trial is looking at two different ways of caring for mothers and their babies after birth to see which one works better and makes mothers feel more satisfied. One type of care is led by nurses and keeps care for the mother and baby separate, while the other is led by midwives and provides a more integrated, combined approach. The study aims to find out if the midwife-led care helps mothers feel more supported, improves their confidence as new parents, and encourages breastfeeding more successfully by the time the baby is four months old.

Women who might join the study are healthy, between 18 and 50 years old, and have given birth to a single baby between 36 and 42 weeks of pregnancy. They also plan to breastfeed and have been considered low-risk by their doctors during delivery. After their baby is born, participants will be randomly assigned to receive either nurse-led or midwife-led care. Being part of the trial means you’ll experience one of these two types of postpartum care, and the researchers will check in with you over the following months to see how satisfied you are and how well you’re adjusting to motherhood. This study has not started recruiting participants yet.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women aged 18 to 50 years at the time of delivery
  • Classified as "low-risk" by the obstetric team in the delivery room
  • Gestational age at birth between 36+0 and 42+0 weeks
  • Singleton birth (only one child born)
  • Intent to breastfeed
  • Consent to participate in the study
  • Exclusion Criteria:
  • Women younger than 18 or older than 50 at the time of delivery
  • Classified as "high-risk" by the obstetric team
  • Multiple birth (e.g., twins, triplets)
  • No intention or ability to breastfeed the newborn

About Medical University Of Vienna

The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.

Locations

Vienna, , Austria

Patients applied

0 patients applied

Trial Officials

Tanja A. Stamm, PhD

Principal Investigator

Institute for Outcomes Research Center for Medical Data Science Medical University of Vienna

Alex Farr, PhD

Study Director

Medical University of Vienna, Dept. of Obstetrics and Gynecology, Division of Feto-Maternal Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported